ஐரோப்பிய டயாலிசிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ardelyx Reports Second Quarter 2021 Financial Results

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative.

Fosun pharmaExchange commission onArdelyx incResearch collaborationCompany annual report on formExchange commissionUs food drug administrationKyowa kirin co ltdVirtual congressEuropean renal associationDrug administrationComplete response letterNew drug applicationEuropean dialysisTransplant associationOption agreement

FDA Approves Finerenone for Slowing CKD in Type 2 Diabetes

FDA Approves Finerenone for Slowing CKD in Type 2 Diabetes
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of chicagoForxiga farxigaGeorge bakrisJanani rangaswamiDrug administrationHypertension centerGeorge washington university school of medicineEuropean renal associationCombining finerenone withGeorge washington university schoolCardiovascular diseaseAmerican heartEuropean dialysisComprehensive hypertension centerAlso shows promise

Kidney Stone Risk Higher Among Men Than Women - Renal and Urology News

Kidney Stone Risk Higher Among Men Than Women - Renal and Urology News
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

Pietro manuel ferraroEuropean renal associationNurse health studyHealth professionals studyEuropean dialysisTransplant associationCattolica del sacro cuoreHealth professionals follow up studyபியட்ரோ மானுவல் ஃபெராரோஐரோப்பிய சிறுநீரகம் சங்கம்செவிலியர் ஆரோக்கியம் படிப்புஆரோக்கியம் ப்ரொஃபெஶநல்ஸ் படிப்புஐரோப்பிய டயாலிசிஸ்மாற்று சங்கம்ஆரோக்கியம் ப்ரொஃபெஶநல்ஸ் பின்தொடரவும் மேலே படிப்பு

Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA Virtual Congress

Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA Virtual Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alan glicklichNoopur liffickviceJonathan barrattChinook therapeutics incEuropean renal associationVirtual congressMayer professorRenal medicineEuropean dialysisTransplant associationInterim resultsClinical activityConference callWebcast detailstoChinook therapeuticsInc chinook therapeutics

Akebia Therapeutics Announces Presentations at ERA-EDTA Virtual Congress 2021

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesKristenk sheppardAkebia therapeutics incJapan ministry of healthDrug administrationVirtual congressEuropean renal associationAkebia therapeuticsEuropean dialysisTransplant associationNephrology dialysis transplantationஒன்றுபட்டது கிஂக்டம்ஒன்றுபட்டது மாநிலங்களில்ஜப்பான் அமைச்சகம் ஆஃப் ஆரோக்கியம்மெய்நிகர் காங்கிரஸ்